Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer
about
Narrowing the Gap: Preserving Repertoire Diversity Despite Clonal Selection during the CD4 T Cell ResponseHow regulatory T cells workVagaries of fluorochrome reporter gene expression in Foxp3+ regulatory T cells.Tunable chemokine production by antigen presenting dendritic cells in response to changes in regulatory T cell frequency in mouse reactive lymph nodes.Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome.Prostate cancer immunotherapy yields superior long-term survival in TRAMP mice when administered at an early stage of carcinogenesis prior to the establishment of tumor-associated immunosuppression at later stages.Immunoregulatory functions of mTOR inhibition.Dendritic cell-targeted pancreatic beta-cell antigen leads to conversion of self-reactive CD4(+) T cells into regulatory T cells and promotes immunotolerance in NOD mice.The transcription cofactor Hopx is required for regulatory T cell function in dendritic cell-mediated peripheral T cell unresponsiveness.Polyclonal adaptive regulatory CD4 cells that can reverse type I diabetes become oligoclonal long-term protective memory cellsHow tolerogenic dendritic cells induce regulatory T cellsHuman osteoclasts are inducible immunosuppressive cells in response to T cell-derived IFN-γ and CD40 ligand in vitroCutting edge: TCR revision affects predominantly Foxp3 cells and skews them toward the Th17 lineage.Maturation of human dendritic cells with Saccharomyces cerevisiae (yeast) reduces the number and function of regulatory T cells and enhances the ratio of antigen-specific effectors to regulatory T cellsTCR-based lineage tracing: no evidence for conversion of conventional into regulatory T cells in response to a natural self-antigen in pancreatic islets.Differential effect of DJ-1/PARK7 on development of natural and induced regulatory T cells.The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells.Role of regulatory T cells in gastrointestinal inflammatory disease.Heterogeneity of natural Foxp3+ T cells: a committed regulatory T-cell lineage and an uncommitted minor population retaining plasticityRole of regulatory T cells during virus infection.Diversity of TCRs on natural Foxp3+ T cells in mice lacking Aire expression.The function of regulatory T cells at the ocular surface: Review.Increased number and function of FoxP3 regulatory T cells during experimental arthritisSevere Developmental B Lymphopoietic Defects in Foxp3-Deficient Mice are Refractory to Adoptive Regulatory T Cell Therapy.A mathematical model of immune activation with a unified self-nonself concept.Abnormal Tr1 differentiation in multiple sclerosis.B cell-regulated immune responses in tumor models and cancer patients.Modeling the repertoire of true tumor-specific MHC I epitopes in a human tumor.Pre-natal/juvenile chlorpyrifos exposure associated with immunotoxicity in adulthood in Swiss albino mice.Therapeutic targeting of FOXP3-positive regulatory T cells using a FOXP3 peptide vaccine WO2008081581.Role of TNF-TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications.
P2860
Q26796086-28A046BD-CBA9-45E2-8610-2A5416CB6762Q29614262-A87B4837-CDB2-493C-B9B1-C120861B383AQ31081160-9EADD40F-2577-4359-BA54-40DE7539DEADQ33515288-FCE03F51-C8CE-4CAD-905D-B33A95A43843Q33596681-85E1A331-2DF0-486F-B6D9-13340D6C5D55Q33606027-8F8A3F5E-1242-4A6A-BE9F-850FAD2B6D80Q33761278-C3C48D25-AA4F-42BA-96AC-4FED052C7717Q34072331-C2400117-7D45-4194-A185-BB5FBCC9084FQ34146070-25FE10BD-B460-4E87-9286-C0E723CA16C1Q34512471-25B0C706-473E-4D6B-8921-5F5014930EB8Q34631825-79E8B2D4-39B5-438B-86FB-C67A10BBAAA9Q34674972-4EE741AF-C6C5-4DAF-90B9-58AF1C032518Q34703648-B6F9A32C-B6DA-4AA7-AA8B-7FA7367DE9D3Q35099116-C6597FE1-E1D8-4DEA-945A-7A1E0D733AF3Q36229637-3911445C-6A42-4055-8B41-BA090747C75BQ36346401-5DB947D7-29D5-44F6-A00B-A87845F64852Q36509846-E7D546E6-C23E-479D-A9E1-4CECAC5980E1Q37090518-C6E0F53B-3BA8-4642-A38A-197843DA8686Q37100901-D7530D5F-D1A6-4627-A5F9-75697C9D86CFQ37107677-0546A385-924A-4E72-8555-A9A18CBBAB36Q37451209-3AF8B22F-8443-4315-8FF0-E37917B801E1Q39347374-361D4C8F-DD84-4BB9-ADE1-404A38B84A0CQ41160548-5EEA96EC-A37E-493B-9AFA-07E512577B80Q42183949-DC2CB2AE-BC3B-43D3-872E-5C758C620E11Q42775633-39009D0C-ABA3-4E46-96B6-736548C35421Q42953557-2FE91027-CC0F-4724-8EA6-01321536B489Q42969728-3CADB8A0-77BB-46A4-AA16-94115FA4B098Q43102307-42460F87-27F2-4918-AA23-D7AFB753EAD7Q46753566-7FB1EF3A-C02E-4D9E-9F50-14D06BC57642Q47761658-7F6F22DD-1576-4713-B7EC-B74B9E3E827CQ55335193-952FD005-D699-4FD4-8F55-56F8CC53EB09
P2860
Making regulatory T cells with defined antigen specificity: role in autoimmunity and cancer
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Making regulatory T cells with ...... ole in autoimmunity and cancer
@ast
Making regulatory T cells with ...... ole in autoimmunity and cancer
@en
type
label
Making regulatory T cells with ...... ole in autoimmunity and cancer
@ast
Making regulatory T cells with ...... ole in autoimmunity and cancer
@en
prefLabel
Making regulatory T cells with ...... ole in autoimmunity and cancer
@ast
Making regulatory T cells with ...... ole in autoimmunity and cancer
@en
P2093
P2860
P1476
Making regulatory T cells with ...... ole in autoimmunity and cancer
@en
P2093
Elmar Jaeckel
Harald von Boehmer
Irina Apostolou
Karsten Kretschmer
Khashayarsha Khazaie
P2860
P304
P356
10.1111/J.0105-2896.2006.00411.X
P577
2006-08-01T00:00:00Z